AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🌍 Showing

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Condition

Country

City (shown first)

28 recruiting trials

for Advanced Biliary Tract Cancer(BTC)

A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer NCT07850791Phase 21 site📍 Beijing Haitao Zhao, MD · Tests: Sacituzumab Tirumotecan (SKB264), Pembrolizumab Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer NCT06467357Phase 3272 sites📍 Scottsdale📍 Tucson📍 Tucson AstraZeneca · Tests: Gemcitabine, Cisplatin, Durvalumab, Trastuzumab deruxtecan, Rilvegostomig Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer NCT07159204Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Paclitaxel polymer micelle immunocombination Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab NCT06648057n/a1 site📍 Seongnam-si CHA University · Tests: lenvatinib plus pembrolizumab Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer NCT06893380n/a1 site📍 Seongnam-si CHA University · Tests: Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab. A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) NCT07229625Phase 31 site📍 Hangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-8068 Injection, Adebrelimab Injection, Gemcitabine Hydrochloride for Injection, Cisplatin Injection, Durvalumab Inj… SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites📍 Glen Burnie📍 Pittsburgh📍 Seoul SK Life Science, Inc. · Tests: SKL35501, SKL35502 GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1） NCT06988592n/a1 site📍 Shanghai Fudan University · Tests: GemCis plus PD-1/PD-L1 inhibitor A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer NCT07265674Phase 318 sites📍 Duarte📍 Orange📍 Santa Monica J-Pharma Co., Ltd. · Tests: Nanvuranlat, Physician's Best Choice Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors NCT04900818Phase 121 sites📍 Orange📍 Aurora📍 Layfayette I-Mab Biopharma US Limited · Tests: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (… A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain NCT07326137n/a1 site📍 Wuhan Tongji Hospital · Tests: First-Line Systemic Therapy, Celiac Plexus Neurolysis (CPN) Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors NCT06975410Phase 1, Phase 24 sites📍 Seoul📍 Seoul📍 Seoul Yuhan Corporation · Tests: YH32364 A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites📍 Duarte📍 Newport Beach📍 Boston SEED Therapeutics, Inc. · Tests: ST-01156 YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies NCT07763301Phase 11 site📍 Chengdu West China Hospital · Tests: YMN-136 vaccine A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) NCT07433673Phase 21 site📍 New York Columbia University · Tests: Cemiplimab D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer NCT06622057Phase 34 sites📍 Tucson📍 Miami Beach📍 Cleveland InnoPharmax Inc. · Tests: D07001-Softgel Capsules, Placebo, Capecitabine A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors NCT06270706Phase 122 sites📍 New Haven📍 Atlanta📍 Grand Rapids Pliant Therapeutics, Inc. · Tests: PLN-101095, PLN-101095, PLN-101095, PLN-101095, PLN-101095 A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221Phase 1, Phase 220 sites📍 Los Angeles📍 Baltimore📍 Boston Verastem, Inc. · Tests: VS-7375, Cetuximab, Carboplatin + Pemetrexed + Pembrolizumab, Gemcitabine + Nab-paclitaxel, Pembrolizumab Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC NCT05733598Phase 212 sites📍 Beverly Hills📍 La Jolla📍 Miami Replimune, Inc. · Tests: RP2, Bevacizumab, Atezolizumab, Durvalumab, RP2 Monotherapy Cosiporfin Sodium for Injection Photodynamic Therapy NCT07398339Phase 21 site📍 Shanghai Shanghai Guangsheng Biopharmaceutical Co., Ltd · Tests: Cosiporfin Sodium for injection, DVDMS, Gemcitabine Hydrochloride for Injection, Cisplatin for injection AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) NCT07038343Phase 1, Phase 227 sites📍 Gilbert📍 Los Angeles📍 Los Angeles Avenzo Therapeutics, Inc. · Tests: AVZO-1418, Combination Agent 1, Combination Agent 2 Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer NCT07710885Phase 321 sites📍 Brisbane📍 Melbourne📍 Perth Taiho Pharmaceutical Co., Ltd. · Tests: Futibatinib, Zimberelimab, Durvalumab, Pembrolizumab, Gemcitabine ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer NCT07151118n/a1 site📍 Seongnam-si CHA University · Tests: Blood Sampling for ctDNA Analysis Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC NCT07142226n/a1 site📍 Seongnam-si CHA University · Tests: Circulating Tumor DNA (ctDNA) Testing (ctDNA-based Next-Generation Sequencing (NGS)) A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer NCT07619235Phase 41 site📍 Wuhan Xianglin Yuan · Tests: Iparomlimab and Toripalimab, Bevacizumab, Gemcitabine (1000 mg/m2), Cisplatin

🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy